We are live on ! Find out more
ASC

Atalanta Sosnoff Capital Portfolio holdings

AUM $5.68B
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+54.21%
3 Year Est. Return
+205.88%
5 Year Est. Return
+308.89%
10 Year Est. Return
+1,480.72%
AUM
$3B
AUM Growth
-$184M
Cap. Flow
-$262M
Cap. Flow %
-8.76%
Top 10 Hldgs %
31.22%
Holding
130
New
19
Increased
32
Reduced
50
Closed
26

Top Sells

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$55M
2
RCL icon
Royal Caribbean
RCL
+$45.4M
3
BSX icon
Boston Scientific
BSX
+$37.6M
4
MA icon
Mastercard
MA
+$35.2M
5
HPE icon
Hewlett Packard
HPE
+$30.2M

Sector Composition

Rank Sector Weight
1 Communication Services 17.64%
2 Healthcare 15.49%
3 Financials 12.68%
4 Energy 10.14%
5 Technology 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$161B
$46.2M 1.54%
1,383,589
-50,481
-4% -$1.61M
C icon
27
Citigroup
C
$223B
$45.9M 1.53%
1,083,733
-262,817
-20% -$11.6M
CVS icon
28
CVS Health
CVS
$120B
$45.6M 1.52%
476,440
-25,855
-5% -$2.58M
DG icon
29
Dollar General
DG
$27B
$45.2M 1.51%
480,365
-200,747
-29% -$17.3M
ZBH icon
30
Zimmer Biomet
ZBH
$19.2B
$43M 1.43%
+367,779
New +$41.6M
WFC icon
31
Wells Fargo
WFC
$260B
$39.9M 1.33%
843,941
-117,697
-12% -$5.74M
VZ icon
32
Verizon
VZ
$205B
$38.2M 1.28%
684,172
-297,633
-30% -$15.4M
BSX icon
33
Boston Scientific
BSX
$75.4B
$35.9M 1.2%
1,535,649
-1,738,640
-53% -$37.6M
AGN
34
DELISTED
Allergan plc
AGN
$35.1M 1.17%
151,842
-78,267
-34% -$18M
BMY icon
35
Bristol-Myers Squibb
BMY
$138B
$33.5M 1.12%
455,918
-28,502
-6% -$2.01M
FDX icon
36
FedEx
FDX
$77.7B
$31.9M 1.06%
210,065
+41,468
+25% +$6.72M
MDT icon
37
Medtronic
MDT
$120B
$31.7M 1.06%
364,826
-21,535
-6% -$1.74M
PEP icon
38
PepsiCo
PEP
$195B
$31.6M 1.06%
298,556
-98,521
-25% -$10.2M
AIG icon
39
American International
AIG
$39.6B
$31.5M 1.05%
594,896
-348,616
-37% -$19.2M
DIS icon
40
Walt Disney
DIS
$185B
$31.4M 1.05%
320,871
-52,027
-14% -$5.2M
PG icon
41
Procter & Gamble
PG
$336B
$31.1M 1.04%
366,903
+345,773
+1,636% +$28.4M
CHTR icon
42
Charter Communications
CHTR
$18.2B
$30M 1%
+131,252
New +$28.2M
BABA icon
43
Alibaba
BABA
$309B
$29.9M 1%
376,102
-26,759
-7% -$2.09M
PXD
44
DELISTED
Pioneer Natural Resource Co.
PXD
$29.4M 0.98%
194,507
-183,979
-49% -$28.9M
MCD icon
45
McDonald's
MCD
$189B
$27.2M 0.91%
226,298
+21,381
+10% +$2.68M
CRM icon
46
Salesforce
CRM
$169B
$27M 0.9%
340,333
+171,655
+102% +$13.5M
CCI icon
47
Crown Castle
CCI
$31.8B
$27M 0.9%
+265,919
New +$24.1M
SYF icon
48
Synchrony
SYF
$25.9B
$26.7M 0.89%
1,055,364
-59,172
-5% -$1.72M
CELG
49
DELISTED
Celgene Corp
CELG
$25.5M 0.85%
258,969
-9,515
-4% -$984K
MRK icon
50
Merck
MRK
$376B
$25.1M 0.84%
456,465
-36,890
-7% -$1.96M

Similar funds

Atalanta Sosnoff Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Atalanta Sosnoff Capital held 130 positions worth $3B, down 5.8% from $3.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Atalanta Sosnoff Capital withdrew a net $262M in Q2 2016, closing 26 positions and reducing 50 holdings. Its most notable exit was Royal Caribbean, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Atalanta Sosnoff Capital opened a new position in Zimmer Biomet worth $43M.

  • Atalanta Sosnoff Capital's largest Q2 2016 buy was Zimmer Biomet: 367,779 shares worth $43M.
  • Atalanta Sosnoff Capital added most to Johnson & Johnson in Q2 2016, an estimated $34.1M increase.
  • Atalanta Sosnoff Capital's biggest Q2 2016 reduction was Delta Air Lines, cutting an estimated $55M.
  • Atalanta Sosnoff Capital fully exited Royal Caribbean in Q2 2016, selling an estimated $45.4M.
  • Atalanta Sosnoff Capital's ten largest holdings make up 31% of its $3B portfolio in Q2 2016.
  • Atalanta Sosnoff Capital opened 19 new positions and closed 26 in Q2 2016.
  • Atalanta Sosnoff Capital's portfolio value fell 5.8% quarter-over-quarter to $3B.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2016, filed 25 Jul 2016.